{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:44:13Z","timestamp":1773409453654,"version":"3.50.1"},"reference-count":42,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T00:00:00Z","timestamp":1123804800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2005,8]]},"abstract":"<jats:p>The aim of the present study was to investigate associations between Pro12Ala and C161T polymorphisms in the peroxisome proliferator\u2010activated receptor\u2010gamma (<jats:italic>PPAR<\/jats:italic>\u2010\u03b3) gene and colorectal cancer (CRC) risk. We recruited 301 newly diagnosed CRC patients and 291 healthy control subjects at the Madras Cancer Institute in Chennai, India, from 1999 to 2001. Genotypes of the Pro12Ala and C161T polymorphisms were determined using the PCR\u2010RFLP method. After adjustment for age, sex, smoking habit, family history and family income, an increased risk of CRC was observed for the C\/T\u00a0+\u00a0T\/T genotype compared to the C\/C genotype of the C161T polymorphism (odds ratio\u00a0=\u00a01.61, 95% confidence interval: 1.10\u20132.36), whereas no significant association was found for Pro12Ala (odds ratio\u00a0=\u00a01.06, 95% confidence interval: 0.70\u20131.61). Analysis with estimated haplotypes showed a significant difference in haplotype frequencies between cases and controls (\u03c7<jats:sup>2<\/jats:sup>\u00a0=\u00a011.62, <jats:italic>P<\/jats:italic>\u00a0=\u00a00.009, d.f.\u00a0=\u00a03). The relationship between the two polymorphisms and CRC risk was not significantly modified by dietary intake of fish. Although the biological mechanisms of the observed association remain to be elucidated, our findings suggest that the C161T polymorphism of the <jats:italic>PPAR<\/jats:italic>\u2010\u03b3 gene is related to risk of CRC. Further research is needed to investigate functional implications of polymorphisms of the <jats:italic>PPAR<\/jats:italic>\u2010\u03b3 gene in CRC development. (<jats:italic>Cancer Sci<\/jats:italic> 2005; 96: 507\u2003\u2013512)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2005.00072.x","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T08:01:49Z","timestamp":1123833709000},"page":"507-512","source":"Crossref","is-referenced-by-count":28,"title":["Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator\u2010activated receptor\u2010gamma on colorectal cancer in an Indian population"],"prefix":"10.1111","volume":"96","author":[{"given":"Jing","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vendhan","family":"Gajalakshmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingweng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyonori","family":"Kuriki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadao","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Akasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinkan","family":"Tokudome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,12]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00210629"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/3099"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(99)00256-4"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4914(01)02076-7"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/19.1.49"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(01)80012-5"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00508.2001"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/2030"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.5.418"},{"key":"e_1_2_6_11_2","first-page":"3344","article-title":"Ligand for peroxisome proliferator\u2010activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo","volume":"58","author":"Kubota T","year":"1998","journal-title":"Cancer Res"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2003.tb01385.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70072-1"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.162480299"},{"key":"e_1_2_6_15_2","first-page":"5307","article-title":"Mutational analysis of the peroxisome proliferator\u2010activated receptor gamma gene in human malignancies","volume":"61","author":"Ikezoe T","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/2042"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.30.18779"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(98)01273-3"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1997.7798"},{"key":"e_1_2_6_20_2","first-page":"3560","article-title":"Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator\u2010activated receptor gamma with colorectal cancer","volume":"63","author":"Landi S","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh343"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh336"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200211000-00003"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(02)00617-1"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004390100563"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.6.410"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304383502007176"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgg110"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.1.2"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/1536867X0100100104","article-title":"Haplotype analysis in population\u2010based association studies","volume":"1","author":"Mander AP","year":"2001","journal-title":"The Stata J"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.3.435"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1096\/fsb2fasebj.12.1.57"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25490"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11668"},{"key":"e_1_2_6_35_2","first-page":"2015","article-title":"Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden","volume":"10","author":"Stattin P","year":"2003","journal-title":"Oncol Rep"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2156-3-21"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1086\/303069"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh008"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200412000-00008"},{"key":"e_1_2_6_40_2","first-page":"485","article-title":"Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild\u2010type K\u2010ras gene","volume":"9","author":"Tomita S","year":"2002","journal-title":"Int J Mol Med"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1470495"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M300363-JLR200"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-200304000-00004"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2005.00072.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2005.00072.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T14:10:09Z","timestamp":1697206209000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2005.00072.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["10.1111\/j.1349-7006.2005.00072.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2005.00072.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}